Last year David Fuehrer and Stephen Goldner didn't know where to go to find new or experimental treatments for illness so they decided to do something about it. The started a business in Bloomfield Hills last summer called cureLauncher.
The Internet start-up now serves as a one-stop source for all new treatments and developments. It launched last fall and is now working to become the Wikipedia of clinical trials for new drugs and treatments.
"We have every enrolling breast cancer trial in the U.S.," says David Fuehrer, vice president & co-founder of
cureLauncher. "It's 400 trials at 7,500 locations. Users can stroll through that list and see what is right for them."
The company is also working to help tackle the clinical trial enrollment problem. It cites that there are 50,000 clinical trials in the U.S. every year, and each one is delayed by 4.6 months due to enrollment issues. The firm hopes to help close that gap by connecting sick people with envelope-pushing treatments that could help them.
Fuehrer and Goldner's start-up recently made the finals of this winter's
ACE business plan competition. The self-funded firm and its team of eight people is now applying for some seed-funding sources, such as financing from the
Michigan Microloan Fund.
Source: David Fuehrer, vice president & co-founder of cureLauncher
Writer: Jon Zemke
Read more about Metro Detroit's growing entrepreneurial ecosystem at SEMichiganStartup.com.
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.